Zitieren

Introduction

The follicle is the principal functional unit of the ovary and mammalian folliculogenesis begins during fetal life. In pigs, the number of follicles at the moment of birth reaches 500 000, however it decreases to 80 000 until puberty. The primordial follicles are formed at day 75 of gestation and comprise of a single layer of flattened granulosa cells (GCs), which surround the oocyte arrested in prophase-1 of meiosis [1]. Further follicular development occurs after puberty, when primordial follicles develop into primary follicles and granulosa cells become cuboidal. Then the secondary follicles are formed, when granulosa cells proliferate and form multiple layers surrounding the oocyte. The fully developed antral follicles are composed of three compartments (a thecal layer with a vascular network, a granulosa cells layer and an oocyte) and in most cases undergo atresia, however few are selected for ovulation [2, 3, 4].

Granulosa cells undergo highly dynamic changes during folliculogenesis and play vital role in oocyte’s maturation, since they remain in close contact with the female gamete. The communication between the oocyte and somatic cells is bi-directional and occurs via gap junctions and paracrine signaling. The female gamete is involved in regulation of folliculogenesis, since it secretes oocyte secreted factors (OSF), which influence follicular cells’ proliferation and differentiation [5], whereas the granulosa cells support the oocyte’s growth and development, as well as regulate global transcriptional activity in its genome [6].

Apart from above described granulosa cells role in oogenesis, it has been shown that they also exhibit stem cell properties, which was first indicated by Kossowska-Tomaszczuk et al. [7]. In this study, the granulosa cells were extracted from the follicular fluid obtained from patients undergoing controlled ovarian hyperstimulation. Reverse transcriptase-PCR revealed expression of a pluripotency marker in luteinizing GCs, namely OCT-4. Moreover, the presence of several mesenchymal stem cell markers (such as CD29, CD44, CD90, CD105, CD117 or CD166) in isolated GCs has been confirmed as well. The multipotency of GCs has also been assessed by their differentiation into neurons, chondrocytes and osteoblasts in vitro [7]. On the contrary, the study conducted by Mattioli et al. revealed the lack of OCT-4 expression in GCs isolated from pigs, however the presence of other stemness markers, namely Nanog, Sox-2 and TERT has been confirmed. The in vitro expansion of cells did not influence these markers’ expression and their osteogenic differentiation potential has been demonstrated both in vitro and in vivo [8].

The stem cells have been a major focus of regenerative medicine in recent years. However, embryonic stem cells (ESCs) utilization involves embryos destruction and may cause teratoma formation or immune rejection after transplant [9], therefore the adult stem cells are emerging as a promising alternative. Granulosa cells seem to provide a promising source of stem cells, particularly since they are present in follicular fluid collected during assisted reproductive techniques, thus are easily obtainable. Further understanding transcriptional changes in proliferating GCs may be helpful for their utilization in cellular therapies, especially those targeted at female infertility [10]. Therefore, the aim of this study was to examine transcriptional changes in porcine GCs during 168 h in vitro culture with the use of RT-qPCR, with a particular focus on their stemness markers expression.

Material and Methods
Animals

A total of 40 pubertal crossbred Landrace gilts with a mean age of 155 days and a mean weight of 100 kg were used for this study. All animals were bred on a local commercial farm and housed under identical conditions. The experiments were approved by the Local Ethics Committee.

Collection of porcine ovaries and in vitro cultivation of porcine granulosa cells (GCs)

Immediately after the slaughter porcine ovaries were collected and placed at prewarmed 0.9% NaCl. Within 40 minutes they were transported to the laboratory and transferred to 5% fetal bovine serum (FBS; Sigma-Aldrich Co., St. Louis, MO, USA) in PBS. Then the follicular fluid was collected from single large follicles (>5 mm) with the use of a 20 G needle to obtain granulosa cells. The follicular fluid was then filtered through 40 μm cell strainer, to remove cumulus-oocyte complexes (COCs), and centrifuged at 200 ×g for 10 min at RT. The supernatant was discarded and GCs were washed twice with culture medium, by centrifugation at 200 ×g for 10 min at RT. Medium consisted of Dulbecco’s Modified Eagle’s Medium (DMEM/F12, Sigma-Aldrich, USA), 2% fetal calf serum FCS (PAA, Austria), 10 mg/mL ascorbic acid (Sigma-Aldrich, USA), 0.05 μM dexamethasone (Sigma-Aldrich, USA), 200 mM L-glutamine (Invitrogen, USA), 10 mg/mL gentamicin (Invitrogen, USA), 10,000 units/mL penicillin, and 10,000 μg/mL streptomycin (Invitrogen, USA). Cells were cultivated at 38.5°C under aerobic conditions (5% CO2) for 168 h.

Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) Analysis

Total RNA was isolated from GCs after 24, 48, 72, 96, 120, 144, and 168 h of culture with the use of RNeasy mini column from Qiagen GmbH (Hilden, Germany). The RNA samples were resuspended in 20 μL of RNase-free water and stored in liquid nitrogen. Before RT-qPCR the RNA samples were subjected to treatment with DNase I and reverse transcribed (RT) into cDNA. 2 μL of cDNA solution was added to 18 μL of a detection dye QuantiTect® SYBR Green PCR (Master Mix Qiagen GmbH, Hilden, Germany) and primers for amplification. One RNA sample of each preparation was processed without the RT-reaction to provide a negative control for subsequent PCR. RT-qPCR was conducted using a LightCycler RT-qPCR detection system (Roche Diagnostics GmbH, Mannheim, Germany) and target cDNA was quantified using the relative quantification method.

Ethical approval

The research related to animal use has been complied with all the relevant national regulations and instructional policies for the care and use of animals. Bioethical Committee approval no. 83/2012/DNT.

Results

We assessed the relative abundance of LIF, IGF1, CD44, CD90 and CD105 mRNA in equal time intervals – after 48, 72, 96, 120, 144 and 168 h in reference to 24 h of GCs in vitro cultivation with the use of RT-qPCR assay. The results are presented in figure 1; the relative changes are expressed in a commonly used logarithmic ratio fold change (FC) scale (the logarithm to base 2 is used, which means that an increase of a quantity by 100 %, i.e. 2-fold, is represented by 1 – FC = 21).

Figure 1

Expression of LIF, IGF1, CD44, CD90 and CD105 mRNA in granulosa cells (GCs) after various periods of in vitro cultivation; the results are expressed in logarithmic fold change scale, with the reference time interval of 24 h

We observed that in case of CD44, CD90 and IGF1 proteins the expression in GCs was elevated during all examined time periods, as compared to the expression observed after 24 h culture. On the other hand, the expression of CD105 and LIF was decreased.

The CD90 expression level was the highest amongst the examined proteins and rose gradually during the cultivation, reaching the highest level of the fold change of almost 28 (with respect to the reference 24 h time interval) at 168 h. The only exception was at the time of 96 h of cultivation, when its expression was not observed to increase as compared to the previously tested time period, namely 72 h of cultivation.

The next protein that exhibited the highest change in expression was IGF1. The maximum fold change in expression, of almost 27, was reached after 120 h. At later periods the expression tended to decrease, down to the approximate fold change value of below 23; this means a 16-fold decrease with respect to the maximum value.

Finally, for the last protein exhibiting the increase of expression, i.e. CD44, the increase was very moderate. The behavior was rather irregular, with two maxima – nearly 22 (ca. 3-fold change) after 72 h of cultivation and above 22 (ca. 5-fold change) after the longest period examined, i.e. 168 h.

The other two proteins investigated suffered a moderate decrease of expression, down to ca. 2−2.

For CD105 the decrease in expression first proceeded approximately monotonically, since a maximum decrease was observed after 144 h. Later the expression seemed to recover, roughly to the level observed after the initial intervals of 48 h and 72 h of cultivation. On the contrary, the behavior of the LIF expression was not regular. The first considerable decrease of expression was noted already after 48 h, then the expression increased again, almost to the value observed after the reference interval of 24 h, but finally an abrupt decrease after the last time span examined (168 h) was noted.

Discussion

In order to better understand the genetic changes taking place in proliferating granulosa cells cultured in vitro, we examined changes in transcript levels in porcine GCs during specific time periods, namely 48, 72, 96, 120, 144 and 168 h of cultivation. We focused on stemness markers expression, such as CD44, CD90 and CD105, as well as on IGF1 and LIF.

Amongst aforementioned genes, the CD44, CD90 and IGF1 were upregulated after in vitro cultivation. The most significant change in expression level was observed in case of CD90, which abundance gradually increased in GCs during tested time periods, reaching the highest level in 168 h of cultivation. CD90, also called THY1, was initially described in mice as a cell surface glycoprotein characteristic to T cells, however it is also present in thymocytes and neurons and is thought to be involved in cell-cell interactions [11]. Apart from that, CD90 is included in the list of antigens that mesenchymal stem cells must possess, according to the International Society for Cellular Therapy, therefore is considered a stemness marker [12]. Its presence has already been demonstrated in human granulosa cells by Kossowska-Tomaszczuk et al. [7] and Dzafic et al. [13] among others. Additionally, CD90 is thought to control cell differentiation in various tissues and its release from vascular pericytes in the ovaries has been linked with follicular differentiation. Indeed, the study conducted by Bukovský revealed that in follicles entering atresia CD90 is strongly released among thecal cells, which results in their high differentiation. On the contrary, in the same study granulosa cells displayed low differentiation, which was associated with lack of CD90 release amongst them [14]. We, on the other hand, report significant increase in CD90 expression in porcine GCs during 168 h in vitro cultivation. Considering previous reports by other investigators, our results may indicate that not only do porcine GCs possess stem cell properties to a certain degree, but also differentiate more intensely in a response to prolonged in vitro culture.

Another upregulated protein in our study was IGF1, however it reached the highest level of expression at 120 h of in vitro culture and declined afterwards. IGF1 (Insulin-like growth factor 1) is involved in growth and developmental processes in mammals and mediates the effects that growth hormone exerts. IGF1 complete amino acid sequence has been determined by Rinderknecht et al. and its homology to proinsulin has been indicated [15]. Although IGF1 is widely distributed throughout the mammalian organism, the liver was found to be the major site of its synthesis [16,17]. In regards of mammalian reproduction, the expression of IGF1 has been described by Oliver et al. in rat GCs of developing preantral and antral follicles [18] and this expression pattern has been observed in murine ovaries by Adashi et al. as well [19]. Since it is not present in atretic follicles or corpora lutea, an assumption has been made that IGF1 is expressed in mitotically active GCs and promotes their replication via an autocrine-paracrine mechanism [20], especially since Igf null mice are infertile and their follicular development is arrested [21]. Additionally, the study conducted by Ogo et al. indicates that Igf1 mRNA expression is regulated by nuclear receptors ERα and ERβ and that IGF1 enhances the estrogen-induced proliferation of GCs [22]. Since we observed increasing expression of IGF1 until 120 h of porcine GCs in vitro culture, we hypothesize that after that time the IGF1-induced proliferation of GCs decreases.

The last of the upregulated genes in our study was CD44, which reached the highest level in 168 h of in vitro cultivation, similarly to CD90. Before that, its expression remained on relatively the same level, with the exception of 72 h, when it was increased. CD44 is a cell membrane glycoprotein thought to be involved in cell attachment to extracellular matrix components, such as hyaluronate, as well as in lymphocyte activation and lymph node homing [23]. Hyaluronic acid causes cell aggregation in many types of cells, stimulates cell proliferation, migration and adhesion, as well as preventing apoptosis in cumulus and granulosa cells in a CD44-dependent manner [24,25]. Another ligand for CD44 is osteopontin and such interaction results in cellular chemotaxis induction, but not homotypic aggregation [26]. Apart from that, CD44 is considered a mesenchymal lineage marker and its presence in human GCs has already been described in a previously mentioned study conducted by Kossowska-Tomaszczuk et al. [7] and by Ohta et al., who suggested that CD44 plays important role in oocyte maturation, since its expression is higher in GCs of mature COCs compared to the immature ones [24]. The abundance of CD44 in porcine GCs has already been confirmed as well, and the parallel relation between the amount of hyaluronic acid and CD44 expression has been indicated [27]. Since the study conducted by Chavoshinejad et al. revealed that IGF1, combined with other factors such as oestradiol, gonadotropins or insulin, stimulated CD44 expression in ovine GCs [28], we conclude that this may be the case in our study, as we observed up-regulation of both of these genes.

Amongst tested genes, CD105 and LIF were downregulated in GCs after in vitro culture. CD105, also called endoglin, is a membrane glycoprotein highly expressed by vascular endothelial cells. It is a component of the transforming growth factor-beta (TGFB) receptor complex and binds TGFB1 with high affinity [29]. Additionally, the International Society for Cellular Therapy included CD105 in the list of antigens that cells must possess in order to be designated mesenchymal stem cells [12]. CD105 null mice die by embryonic day 11.5 due to failure of endothelial remodeling [30], however, apart from playing an undoubtable role in vasculature development, endoglin is also involved in GCs function, since it is expressed by this type of cells [7,10,31]. It is generally accepted that follicle development is dependent on the establishment and continual remodeling of a complex vascular system, and was suggested that GCs may behave as endothelial cells and contribute to follicular angiogenesis [32]. Indeed, the study on porcine GCs conducted by Basini et al. revealed that these cells express several endothelial markers, including CD105, and that this expression seems to be more pronounced in cells cultured in specific endothelial cell culture medium (EBM-2) [32]. We however observed gradual decrease of CD105 levels during porcine GCs in vitro culture, reaching the lowest level at 144 h, therefore it seems that in our culture conditions GCs lose their angiogenic potential. It is also possible, that a longer in vitro cultivation would result in restoration of their endothelial-like properties, since the expression of CD105 was significantly higher in 168 h of culture.

LIF (Leukemia-inhibitory factor) is a pleiotropic cytokine playing a crucial role in an embryo implantation in mice, since it is highly produced by endometrium and the trophoblast, while cytotrophoblast cells express its receptor [33]. Moreover, LIF is responsible for signal integration into mouse embryonic stem cells for their self-renewal and pluripotency maintenance [34], as well as for regulation of microvessel density by modulating oxygen-dependent VEGF expression in mice [35]. Leukemia-inhibitory factor has also been found to be expressed in human; both fetal and adult ovaries, suggesting its role in primordial follicles growth initiation [36]. Such notion has been confirmed by Nilsson et al., who observed that LIF treatment increases the primordial to primary rat follicle transition, possibly due to its interaction with Kit ligand [37]. In regards of granulosa cells, Kossowska-Tomaszczuk et al. demonstrated that the presence of LIF in culture medium promotes multipotent GCs survival in vitro. Such cultured cells exhibited reduced expression of neurogenic, chondrogenic or osteogenic differentiation markers, comparing to those cultured in medium without the addition of LIF. Therefore, culture medium supplemented with LIF allowed the selection of less differentiated GCs [7]. Since LIF is thought to maintain stemness potential of cells, its downregulation in our study may indicate that porcine GCs start to differentiate in 168 h of in vitro cultivation. This assumption is consistent with an increased CD90 expression, which also suggests these cells differentiation.

To summarise, our results confirm stemness potential of porcine GCs, since they express markers such as CD90, CD44 or CD105. The downregulation of CD105 may indicate that their intrinsic endothelial potential is reduced after in vitro cultivation and an increased CD90 and decreased LIF level suggests that these cells start to differentiate. Additionally, we observed upregulation of IGF1 and CD44. Since both of these proteins are thought to cooperate in regulation of cell proliferation, we conclude that this may be the case in our study, especially because CD44 has been proven to prevent GCs from apoptosis. Our results provide an insight into the transcriptome changes in porcine GCs during in vitro cultivation, however it is important to remember that these changes may not be an exact reflection of processes taking place in physiological conditions.

eISSN:
2544-3577
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Biologie, Molekularbiologie, Biochemie